BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24367678)

  • 1. Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcome.
    Bonnet M; Baudin E; Jani IV; Nunes E; Verhoustraten F; Calmy A; Bastos R; Bhatt NB; Michon C
    PLoS One; 2013; 8(12):e84585. PubMed ID: 24367678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
    Naidoo K; Yende-Zuma N; Padayatchi N; Naidoo K; Jithoo N; Nair G; Bamber S; Gengiah S; El-Sadr WM; Friedland G; Abdool Karim S
    Ann Intern Med; 2012 Sep; 157(5):313-24. PubMed ID: 22944873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
    Meintjes G; Stek C; Blumenthal L; Thienemann F; Schutz C; Buyze J; Ravinetto R; van Loen H; Nair A; Jackson A; Colebunders R; Maartens G; Wilkinson RJ; Lynen L;
    N Engl J Med; 2018 Nov; 379(20):1915-1925. PubMed ID: 30428290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
    Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors of immune reconstitution inflammatory syndrome in HIV-TB coinfected patients.
    Dibyendu D; Sarkar RN; Phaujdar S; Bhattacharyya K; Pal HK
    Braz J Infect Dis; 2011; 15(6):553-9. PubMed ID: 22218514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in initiating ART among HIV-Infected patients in China-risk factors and management.
    Yang H; Liu Q; Wu Y; He K; Zeng Q; Liu M
    BMC Infect Dis; 2024 Jan; 24(1):5. PubMed ID: 38166781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
    Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
    J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of paradoxical tuberculosis associated immune reconstitution inflammatory syndrome among HIV-infected patients in Beijing, China.
    Xue M; Xie R; Pang Y; Yan S; Du Y; Guan C; Chen B
    BMC Infect Dis; 2020 Jul; 20(1):554. PubMed ID: 32736608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
    del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Lodi S; van Sighem A; de Wolf W; Sabin C; Bansi L; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Toulomi G; Gargalianos P; Costagliola D; Abgrall S; Hernán MA;
    Clin Infect Dis; 2012 May; 54(9):1364-72. PubMed ID: 22460971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy.
    Smith K; Kuhn L; Coovadia A; Meyers T; Hu CC; Reitz C; Barry G; Strehlau R; Sherman G; Abrams EJ
    AIDS; 2009 Jun; 23(9):1097-107. PubMed ID: 19417581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study.
    Janssen S; Osbak K; Holman R; Hermans S; Moekotte A; Knap M; Rossatanga E; Massinga-Loembe M; Alabi A; Adegnika A; Meenken C; van Vugt M; Kremsner PG; Meintjes G; van der Poll T; Grobusch MP
    Infection; 2017 Oct; 45(5):669-676. PubMed ID: 28349491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune reconstruction inflammatory syndrome in HIV infection: beyond what meets the eye.
    Sereti I
    Top Antivir Med; 2020 Jan; 27(4):106-111. PubMed ID: 32224502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study.
    Murdoch DM; Venter WD; Feldman C; Van Rie A
    AIDS; 2008 Mar; 22(5):601-10. PubMed ID: 18317001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART.
    Worodria W; Massinga-Loembe M; Mayanja-Kizza H; Namaganda J; Kambugu A; Manabe YC; Kestens L; Colebunders R
    Clin Dev Immunol; 2011; 2011():758350. PubMed ID: 21197091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients.
    Valin N; Pacanowski J; Denoeud L; Lacombe K; Lalande V; Fonquernie L; Girard PM; Meynard JL
    AIDS; 2010 Jun; 24(10):1519-25. PubMed ID: 20549841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and frequency of tuberculosis-associated immune reconstitution inflammatory syndrome among HIV/Tuberculosis co-infected patients in Southern India.
    Vignesh R; Swathirajan CR; Solomon SS; Shankar EM; Murugavel KG
    Indian J Med Microbiol; 2017; 35(2):279-281. PubMed ID: 28681821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of antiretroviral therapy with tuberculosis treatment.
    Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray AL; Gengiah T; Gengiah S; Naidoo A; Jithoo N; Nair G; El-Sadr WM; Friedland G; Abdool Karim Q
    N Engl J Med; 2011 Oct; 365(16):1492-501. PubMed ID: 22010915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis Immune Reconstitution Inflammatory Syndrome in children initiating Antiretroviral Therapy for HIV infection: A systematic literature review.
    Link-Gelles R; Moultrie H; Sawry S; Murdoch D; Van Rie A
    Pediatr Infect Dis J; 2014 May; 33(5):499-503. PubMed ID: 24736441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological characterisation of an unmasking TB-IRIS case.
    Wilkinson KA; Meintjes G; Seldon R; Goliath R; Wilkinson RJ
    S Afr Med J; 2012 Mar; 102(6):512-7. PubMed ID: 22668952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.